Antidepressants and, suicide and self-injury: Causal or casual association?

International Journal of Psychiatry in Clinical Practice

Volumn 20, Issue 1, 2016, Pages 47-51

  Pozzi, Marco ^a   Radice, Sonia ^b   Clementi, Emilio ^a,b   Molteni, Massimo ^a   Nobile, Maria ^a,c  

^a SCIENTIFIC INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Hermanas Hospitalarias ^*  (Italy)

Author keywords

Antidepressants; Paediatric; Self injury; Suicide

Indexed keywords

ANTIDEPRESSANT AGENT; DULOXETINE; FLUOXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; VORTIOXETINE;

ARTICLE; AUTOMUTILATION; COGNITIVE THERAPY; DEPRESSION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; HUMAN; INCIDENCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDE; SYSTEMATIC REVIEW; CHEMICALLY INDUCED; DEPRESSIVE DISORDER; RISK FACTOR; SELF-INJURIOUS BEHAVIOR; STATISTICS AND NUMERICAL DATA;

ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; DEPRESSIVE DISORDER; HUMANS; RISK FACTORS; SELF-INJURIOUS BEHAVIOR; SUICIDE;

EID: 84956581889     PISSN: 13651501     EISSN: 14711788     Source Type: Journal    
DOI: 10.3109/13651501.2015.1117111     Document Type: Article

References (29)

1. Adegbite-Adeniyi C, Gron B, Rowles BM, Demeter CA, Findling RL. 2012. An update on antidepressant use and suicidality in pediatric depression. Expert Opin Pharmacother 13: 2119-2130.
2. Alam MY, Jacobsen PL, Chen Y, Serenko M, Mahableshwarkar AR. 2014. Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study. Int Clin Psychopharmacol 29:36-44.
3. Bjö rkenstam C, Mö ller J, Ringbäck G, Salmi P, Hallqvist J, Ljung R. 2013. An association between initiation of selective serotonin reuptake inhibitors and suicide-a nationwide register-based case-crossover study. PLoS One 8:e73973.
4. Canadian Agency for Drugs and Technologies in Health, Ottawa (ON). 2015. Second generation antidepressants for pediatric patients with major depressive disorder and anxiety disorder: a review of the clinical effectiveness and safety [Internet]. CADTH Rapid Response Reports 2015, June 11; [cited 2015 October 19]. Available from: https:// www.cadth.ca/second-generation-antidepressants-pediatric-patients-major-depressive-disorder-and-anxiety-disorder.
5. Carroll BJ. 2013. Suicide risk and efficacy of antidepressant drugs. JAMA Psychiatry 70:123-124.
6. Cooper WO, Callahan ST, Shintani A, Fuchs DC, Shelton RC, Dudley JA, et al. 2014. Antidepressants and suicide attempts in children. Pediatrics 133:204-210.
7. Ferrer P, Ballarín E, Sabaté M, Vidal X, Rottenkolber M, Amelio J, et al. 2014. Antiepileptic drugs and suicide: a systematic review of adverse effects. Neuroepidemiology 42:107-120.
8. Friedman RA. 2014. Antidepressants' black-box warning-10 years later. N Engl J Med 371:1666-1668.
9. Garlow SJ, Kinkead B, Thase ME, Judd LL, Rush AJ, Yonkers KA, et al. 2013. Fluoxetine increases suicide ideation less than placebo during treatment of adults with minor depressive disorder. J Psychiatr Res 47:1199-1203.
10. Garlow SJ. 2014. Response to the letter from Marc B Stone, MD; Tarek A Hammad, MD, PhD, MSc, MS. J Psychiatr Res 48:133-134.
11. Gibbons RD, Brown CH, Hur K, Davis JM, Mann JJ. 2013a. Inappropriate data and measures lead to questionable conclusions-reply. JAMA Psychiatry 70:122-123.
12. Gibbons RD, Brown CH, Hur K, Davis JM, Mann JJ. 2013b. Suicide risk and efficacy of antidepressant drugs-reply. JAMA Psychiatry 70:123-125.
13. Gibbons RD, Coca Perraillon M, Hur K, Conti RM, Valuck RJ, Brent DA. 2015. Antidepressant treatment and suicide attempts and self-inflicted injury in children and adolescents. Pharmacoepidemiol Drug Saf 24:208-214.
14. Gordon MS, Melvin GA. 2014. Do antidepressants make children and adolescents suicidal? J Paediatr Child Health 50:847-854.
15. Hetrick SE, McKenzie JE, Cox GR, Simmons MB, Merry SN. 2012. Newer generation antidepressants for depressive disorders in children and adolescents. Cochrane Database Syst Rev 11:CD004851.
16. Ho D. 2012. Antidepressants and the FDA's black-box warning: determining a rational public policy in the absence of sufficient evidence. Virtual Mentor 14:483-488.
17. Hoffmann F, Glaeske G, Bachmann CJ. 2014. Trends in antidepressant prescriptions for children and adolescents in Germany from 2005 to 2012. Pharmacoepidemiol Drug Saf 23:1268-1272.
18. Jacobsen PL, Harper L, Chrones L, Chan S, Mahableshwarkar AR. 2015. Safety and tolerability of vortioxetine (15 and 20 mg) in patients with major depressive disorder: results of an open-label, flexible-dose, 52-week extension study. Int Clin Psychopharmacol 30:255-264.
19. Mahableshwarkar AR, Jacobsen PL, Chen Y, Serenko M, Trivedi MH. 2015a. A randomized, double-blind, duloxetine-refer-enced study comparing efficacy and tolerability of 2 fixed doses of vortioxetine in the acute treatment of adults with MDD. Psychopharmacology 232:2061-2070.
20. Mahableshwarkar AR, Jacobsen PL, Serenko M, Chen Y, Trivedi MH. 2015b. A randomized, double-blind, placebo-controlled study of the efficacy and safety of 2 doses of vortioxetine in adults with major depressive disorder. J Clin Psychiatry 76:583-591.
21. Miller M, Pate V, Swanson SA, Azrael D, White A, Stürmer T. 2014. Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA. CNS Drugs 28:79-88.
22. Olfson M, Gerhard T. 2015. Re-examining antidepressant risk of self-injury in children and adolescents. Pharmacoepidemiol Drug Saf 24:215-217.
23. Perlis RH, Uher R, Perroud N, Fava M. 2012. Do suicidal thoughts or behaviors recur during a second antidepressant treatment trial? J Clin Psychiatry 73:1439-1442.
24. Rucci P, Frank E, Scocco P, Calugi S, Miniati M, Fagiolini A, et al. 2011. Treatment-emergent suicidal ideation during 4 months of acute management of unipolar major depression with SSRI pharmacotherapy or interpersonal psychotherapy in a randomized clinical trial. Depress Anxiety 28:303-309.
25. Spielmans GI, Jureidini J, Healy D, Purssey R. 2013. Inappropriate data and measures lead to questionable conclusions. JAMA Psychiatry 70:121-122.
26. Stone MB. 2014. The FDA warning on antidepressants and suicidality-why the controversy? N Engl J Med 371: 1668-1671.
27. Stone MB, Hammad TA. 2014. Fluoxetine and suicidal ideation in minor depression. J Psychiatr Res 48:131-132.
28. Strawn JR, Prakash A, Zhang Q, Pangallo BA, Stroud CE, Cai N, et al. 2015. A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder. J Am Acad Child Adolesc Psychiatry 54:283-293.
29. Wijlaars LP, Nazareth I, Whitaker HJ, Evans SJ, Petersen I. 2013. Suicide-related events in young people following prescription of SSRIs and other antidepressants: a self-controlled case series analysis. BMJ Open 3:e003247.